HCAT

NASDAQStock

Health Catalyst, Inc.

$1.34-0.45 (-24.86%)

52-Week Range

$1.62

$4.60

Key Stats

Market Cap

95.1M

P/E Ratio

—

Dividend Yield

—

Beta

1.78

Volume

2.3M

Avg Volume

901.5K

Performance

-2.72%

-23.83%

-40.53%

YTD

-21.49%

-56.76%

-85.06%

-96.29%

Price Chart

ETF Exposure

HCAT is held by 57 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	17	$50	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	4,818	$10K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,058,272	$4.4M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	10,826	$32K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	933	$3K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	80,617	$12K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	80,617	$4K	$3.91B	0.07%

PreviousPage 2 of 2

About HCAT ETF Exposure

Health Catalyst, Inc. (HCAT) is held by 57 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 95.1M, HCAT is a widely held institutional stock. The stock currently trades at $1.34. Investors can gain exposure to HCAT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HCAT, sorted by portfolio weight.